BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38676733)

  • 21. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O; Linares E; Tilki D; Capitanio U; Evans CP; Montorsi F; Martínez-Salamanca JI; Libertino J; Gontero P; Palou J
    Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.
    Kim JK; Kim H; Lee H; Oh JJ; Lee S; Hong SK; Kwak C; Byun SS
    BMC Cancer; 2021 May; 21(1):592. PubMed ID: 34024273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?
    Palacios DA; Zabor EC; Munoz-Lopez C; Roversi G; Mahmood F; Abramczyk E; Kelly M; Wilson B; Abouassaly R; Campbell SC
    Eur Urol; 2021 Jun; 79(6):774-780. PubMed ID: 33678521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
    Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH
    BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are markers of survival associated with perioperative outcomes for tumor thrombectomy patients?
    Fang AM; Leahy S; Saidian A; Oster RA; Nix JW; Sudarshan S; Rais-Bahrami S; Peyton CC
    Urol Oncol; 2023 Aug; 41(8):358.e17-358.e24. PubMed ID: 37301680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
    Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy.
    Bravi CA; Vertosick E; Benfante N; Tin A; Sjoberg D; Hakimi AA; Touijer K; Montorsi F; Eastham J; Russo P; Vickers A
    Eur Urol; 2019 Sep; 76(3):398-403. PubMed ID: 31080127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer.
    Ebbing J; Menzel F; Frumento P; Miller K; Ralla B; Fuller TF; Busch J; Collins JW; Adding C; Seifert HH; Ardelt P; Wetterauer C; Westhoff T; Kempkensteffen C
    BMC Nephrol; 2019 Feb; 20(1):40. PubMed ID: 30717692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.
    Peyton CC; Abel EJ; Chipollini J; Boulware DC; Azizi M; Karam JA; Margulis V; Master VA; Matin SF; Raman JD; Sexton WJ; Wood CG; Spiess PE
    Eur Urol Focus; 2020 Jan; 6(1):104-111. PubMed ID: 30206003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
    BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study.
    Gontero P; Mari A; Marra G; Nazzani S; Allasia M; Antonelli A; Barale M; Brunocilla E; Capitanio U; Di Maida F; Gallioli A; Longo N; Montorsi F; Porpiglia F; Porreca A; Rocco B; Simeone C; Schiavina R; Tellini R; Terrone C; Villari D; Ficarra V; Carini M; Minervini A
    Urol Oncol; 2021 Jan; 39(1):78.e17-78.e26. PubMed ID: 33127300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.
    Kopp RP; Liss MA; Mehrazin R; Wang S; Lee HJ; Jabaji R; Mirheydar HS; Gillis K; Patel N; Palazzi KL; Wan JY; Patterson AL; Derweesh IH
    Urology; 2015 Aug; 86(2):312-9. PubMed ID: 26189330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
    Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
    Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy.
    Wenzel M; Yu H; Uhlig A; Würnschimmel C; Wallbach M; Becker A; Fisch M; Chun FKH; Meyer CP; Leitsmann M
    Int Urol Nephrol; 2021 Oct; 53(10):2041-2049. PubMed ID: 34269968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy.
    Freifeld Y; Woldu SL; Singla N; Clinton T; Bagrodia A; Hutchinson R; Lotan Y; Margulis V
    Eur Urol Oncol; 2019 Nov; 2(6):691-698. PubMed ID: 31411983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New-onset Chronic Kidney Disease After Surgery for Localised Renal Masses in Patients with Two Kidneys and Preserved Renal Function: A Contemporary Multicentre Study.
    Pecoraro A; Roussel E; Amparore D; Mari A; Grosso AA; Checcucci E; Montorsi F; Larcher A; Van Poppel H; Porpiglia F; Capitanio U; Minervini A; Albersen M; Serni S; Campi R
    Eur Urol Open Sci; 2023 Jun; 52():100-108. PubMed ID: 37284048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
    Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
    Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.